These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 8891830

  • 1. Vitiligo associated with metastatic malignant melanoma.
    Cavallari V, Cannavò SP, Ussia AF, Moretti G, Albanese A.
    Int J Dermatol; 1996 Oct; 35(10):738-40. PubMed ID: 8891830
    [No Abstract] [Full Text] [Related]

  • 2. [Vitiliginous depigmentation in patients suffering from malignant melanoma].
    Frenk E.
    Dermatologica; 1969 Oct; 139(1):84-91. PubMed ID: 5810156
    [No Abstract] [Full Text] [Related]

  • 3. Complete remission of metastatic malignant melanoma after surgery in association with development of systemic vitiligo.
    Nishitani N, Bito T, Ikeda T, Tokura Y, Nishigori C.
    J Dermatol; 2010 Aug; 37(8):770-2. PubMed ID: 20649729
    [No Abstract] [Full Text] [Related]

  • 4. Metastatic melanoma and vitiligo: a case report.
    Buljan M, Situm M, Lugović L, Vucić M.
    Acta Dermatovenerol Croat; 2006 Aug; 14(2):100-3. PubMed ID: 16859616
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vitiligo associated with malignant melanoma and lupus erythematosus.
    Gül U, Kiliç A, Tulunay O, Kaygusuz G.
    J Dermatol; 2007 Feb; 34(2):142-5. PubMed ID: 17239155
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Malignant melanoma and vitiligo.
    Balabanov K, Andreev VC, Tchernozemski I.
    Dermatologica; 1969 Feb; 139(3):211-9. PubMed ID: 5808472
    [No Abstract] [Full Text] [Related]

  • 9. Adult-onset leukoderma and malignant melanoma.
    Gross DJ, Singer PG, Schosser RH.
    Arch Dermatol; 1990 Sep; 126(9):1240-1. PubMed ID: 2396849
    [No Abstract] [Full Text] [Related]

  • 10. Hypopigmentation, vitiligo, and melanoma. New data, more enigmas.
    Nordlund JJ.
    Arch Dermatol; 1987 Aug; 123(8):1005-8. PubMed ID: 3631979
    [No Abstract] [Full Text] [Related]

  • 11. Images in clinical medicine. Vitiligo and cutaneous melanoma.
    Redondo P, Del Olmo J.
    N Engl J Med; 2008 Jul 17; 359(3):e3. PubMed ID: 18635425
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo.
    Le Gal FA, Avril MF, Bosq J, Lefebvre P, Deschemin JC, Andrieu M, Dore MX, Guillet JG.
    J Invest Dermatol; 2001 Dec 17; 117(6):1464-70. PubMed ID: 11886510
    [Abstract] [Full Text] [Related]

  • 16. Hypopigmented malignant melanoma simulating vitiligo.
    Kossard S, Commens C.
    J Am Acad Dermatol; 1990 May 17; 22(5 Pt 1):840-2. PubMed ID: 2347968
    [No Abstract] [Full Text] [Related]

  • 17. Behavior of pigment cells on lesions of the pigmented venus with vitiligo.
    Hamada T, Sakurane HF, Saito T.
    J Dermatol; 1979 Jun 17; 6(3):143-52. PubMed ID: 393743
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.
    Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M, Kenyon K, Davis MM, Riddell SR, Greenberg PD.
    J Exp Med; 2000 Dec 04; 192(11):1637-44. PubMed ID: 11104805
    [Abstract] [Full Text] [Related]

  • 20. [Vitiligo as an undesired side-effect in the management of melanoma. A contribution to experimental vitiligo research].
    Friederich HC.
    Arch Klin Exp Dermatol; 1967 Dec 04; 229(2):223-30. PubMed ID: 5588112
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.